Skip to content

Microatheter-targeted intracoronary thrombolysis in acute ST-elevation myocardial infarction patient with high thrombus burden: A multicenter and randomized clinical trial.

Microatheter-targeted intracoronary thrombolysis in acute ST-elevation myocardial infarction patient with high thrombus burden: A multicenter and randomized clinical trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033350
Enrollment
Unknown
Registered
2020-05-29
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

STEMI patients with high thrombus burden

Interventions

Microcatheter-targeted thrombolysis group:Microcatheter-targeted intracoronary thrombolysis
Thrombus aspiration group:Conventional intracoronary thrombus aspiration

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Between 18 and 80 years old; 2. STEMI patients undergoing primary PCI within 12 hours after the onset of symptoms; 3. Total occlusion of the culprit artery with high thrombus burden after guidewire passes the lesion (TIMI thrombus grade >= 3).

Exclusion criteria

Exclusion criteria: 1. Rescue-PCI; 2. Previous coronary bypass grafting; 3. The predicted survival time less than 12 months due to non-cardiac diseases; 4. Active bleeding, bleeding diseases or known bleeding tendency within 6 months; 5. Sever hepatic or renal dysfunction; 6. Pregnancy or lactation; 7. Uncontrolled hypertension (>180/100mmHg); 8. Previous hemorrhagic stroke in any time or ischemic stroke within 3 months; 9. Cardiopulmonary resuscitation; 10. No informed consent or failure to complete all the treatment or follow-up according to the protocol.

Design outcomes

Primary

MeasureTime frame
Incidence of maior adverse cardiovascular events during six-month follow up;The incidence of stroke or bleeding during 30-day follow up;

Secondary

MeasureTime frame
Myocardial blush grade after procedure;ST segment resolution after procedure;Ratio of TIMI flow grade 3;The incidence of MACEs during 30-day follow up;The incidence of MACEs during three-month follow up;Side-branch occlusion;

Countries

China

Contacts

Public ContactJingang Zheng

China-Japan Friendship Hospital

mdjingangzheng@163.com+86 18519805577

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026